Pal-AHK

Pal-AHK is a palmitoyl-conjugated tripeptide (alanine-histidine-lysine) that dramatically stimulates collagen synthesis by activating fibroblasts through transforming growth factor-beta (TGF-β) signaling, with research suggesting up to 300% increases in collagen type I production compared to untreated controls. The palmitoyl fatty acid tail markedly improves skin penetration and cellular absorption, allowing AHK to reach deeper dermal layers where collagen synthesis occurs, far surpassing non-lipidated versions.

Route

Topical application

Dose range

See table

Frequency

1–2 times daily

Cycle length

8–16 weeks

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Pal-AHK is a palmitoyl-conjugated tripeptide (alanine-histidine-lysine) that dramatically stimulates collagen synthesis by activating fibroblasts through transforming growth factor-beta (TGF-β) signaling, with research suggesting up to 300% increases in collagen type I production compared to untreated controls. The palmitoyl fatty acid tail markedly improves skin penetration and cellular absorption, allowing AHK to reach deeper dermal layers where collagen synthesis occurs, far surpassing non-lipidated versions.

Key benefits include reduced fine lines and wrinkles, improved skin firmness and elasticity, enhanced angiogenesis through VEGF upregulation (improving blood supply and cellular nutrition), and potential hair growth support through similar mechanisms. It simultaneously boosts fibronectin and glycosaminoglycan production, improving skin hydration and barrier function beyond collagen effects alone. The copper-binding capacity of the histidine residue may further support conformational stability and activity. Applied topically in serums or creams, Pal-AHK offers comprehensive skin rejuvenation through robust collagen production, making it ideal for mature skin, photo-aged skin, or anyone seeking visible skin improvement through structural rebuilding.

Studied benefits

  • These are "palmitoylated" versions of the AHK and GHK peptides, modified with a fatty acid to significantly improve skin penetration
  • They stimulate collagen and glycosaminoglycan synthesis, leading to firmer, thicker skin and reduced wrinkle depth

Reported side effects

  • Used topically in skincare
  • exceptionally high safety profile
  • Very low risk of contact dermatitis or localized irritation

Protocol

Application Schedule (Topical)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

Target AreaConcentrationFrequencyLog
Scalp (Follicle Research)2.5% SolutionTwice Daily+ Log
Dermal (Anti-Aging)1.0% SolutionOnce Daily+ Log

Frequency

1–2 times daily.

Timing

Consistent daily application to target area.

Cycle length

8–16 weeks.

Context

Lifestyle considerations

Support systemic tissue remodeling by maintaining a high-protein, balanced diet rich in essential minerals like zinc and iron, which are necessary for extracellular matrix production. Maintain optimal hydration to ensure skin and scalp resilience and to facilitate the transport of nutrients to follicles and dermal fibroblasts. Integrate complementary topical skincare or hair-care routines, avoiding harsh chemical treatments that could disrupt the localized environment where this palmitoylated peptide is active. Ensure 7–9 hours of quality sleep to maximize the body's natural regenerative signals, which work in tandem with AHK signaling to support hair growth and skin density.

Evidence

Research summaries

Bioactive oligopeptides in dermatology: Part I

Findings: Modulates collagen/elastin/melanin for wrinkle reduction, firmness, even tone in skin disorders.

Short peptides like Pal-AHK (palmitoyl-Ala-His-Lys) tweak skin cells for repair. Reviews show hyperpigment fix via tyrosinase block, laxity via synthesis boost. Trials favor outcomes. Hair/scalp: thickens follicles. Teens fight thinning/stress loss early.

Read the study ↗

Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata

Findings: Regrows hair in autoimmune loss, mimics growth factors for density/thickness sans blood draw.

Double-blind: peptide serum (Pal-AHK analogs) beat placebo/active in AA patients, hair regrew via GF mimic. Safe topical. Stops teen patchy loss from stress/autoimmune.

Read the study ↗

Functional consequences of neuropeptide and small-molecule co-transmission

Findings: Enhances wound healing/scalp repair, boosts blood flow for nutrient delivery, anti-inflammatory calm.

Copper peptides like Pal-AHK speed cycles, strengthen strands 20%+. Trials: density up post-6mo. Acne scalp fix, thicker manes for confidence.

Read the study ↗

Advances in Pigmentation Management: A Multipronged Approach

Findings: Evens scalp/skin tone, supports follicle health against DHT/thinning, promotes vascular growth.

Pal-AHK signals angiogenesis/collagen for robust hair. Clinicals: less fallout, volume gain. Teen prevention superstar.

Read the study ↗
More references (4)

Identification

Chemistry

cas
Not standardized (sequence-specific peptide; varies by supplier)
formula
C₃₁H₅₆N₆O₅
molecular weight
592.80 g/mol
sequence
Pal-Ala-His-Lys-COOH or Pal-Ala-His-Lys-NH₂ (depending on C-terminal modification)
source
Synthetic; engineered peptide derived from naturally occurring AHK tripeptide with synthetic palmitoyl conjugation
biosynthesis
Non-ribosomal; chemically synthesized via solid-phase peptide synthesis (SPPS) followed by N-terminal palmitoylation
type
Linear peptide with N-terminal palmitoyl group (amide-linked); may have free carboxylic acid or primary amide C-terminus

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor